Tumors resurrect an embryonic vascular program to escape immunity-Reference-Cited by-同舟云学术

Tumors resurrect an embryonic vascular program to escape immunity

Published:2022-01-14 Issue:67 Volume:7 Page:
ISSN:2470-9468
Container-title:Science Immunology
language:en
Short-container-title:Sci. Immunol.

Author:

Huijbers Elisabeth J. M.¹^ORCID,Khan Kabir A.²^ORCID,Kerbel Robert S.²,Griffioen Arjan W.¹^ORCID

Affiliation:

1. Angiogenesis Laboratory, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.

2. Biological Sciences Platform, Sunnybrook Research Institute, Department of Medical Biophysics, University of Toronto, Toronto, Canada.

Abstract

Tumors escape immunity by using embryonic-like angiogenesis resulting in nonadhesive vasculature, preventing leukocyte infiltration.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine,Immunology

Reference155 articles.

1. Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

2. Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

3. Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa

4. Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?

5. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges in validation of combination treatment strategies for CRC using patient-derived organoids;Journal of Experimental & Clinical Cancer Research;2024-09-11

2. Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes;Molecular Cancer;2024-09-09

3. N6-methyladenosine-dependent signaling in colorectal cancer: Functions and clinical potential;Critical Reviews in Oncology/Hematology;2024-06

4. Single-cell signatures identify microenvironment factors in tumors associated with patient outcomes;Cell Reports Methods;2024-06

5. Targeting senescent cells to reshape the tumor microenvironment and improve anticancer efficacy;Seminars in Cancer Biology;2024-06